$107.89
1.151.08%
At close: -
$108.00
0.110.10%
After Hours: 7:52 PM EDT
Comments
Loading...
Gilead Sciences Stock Guidance | NASDAQ:GILD | Benzinga
Gilead Sciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/11/2025 | GILD | Gilead Sciences | FY | 2025 | $7.70 | $8.10 | $7.60 | $28.20B | $28.60B | $28.41B | Get Alert |
| 11/06/2024 | GILD | Gilead Sciences | FY | 2024 | $4.25 | $4.45 | $3.81 | $27.80B | $28.10B | $27.72B | Get Alert |
| 08/08/2024 | GILD | Gilead Sciences | FY | 2024 | $3.60 | $3.90 | $3.75 | $27.10B | $27.50B | $27.58B | Get Alert |
| 04/25/2024 | GILD | Gilead Sciences | FY | 2024 | $3.45 | $3.85 | $3.67 | $27.10B | $27.50B | $25.69B | Get Alert |
| 02/06/2024 | GILD | Gilead Sciences | FY | 2024 | $6.85 | $7.25 | $7.21 | $27.10B | $27.50B | $27.66B | Get Alert |
| 11/07/2023 | GILD | Gilead Sciences | FY | 2023 | $6.65 | $6.85 | $6.25 | $26.70B | $26.90B | $25.34B | Get Alert |
| 08/03/2023 | GILD | Gilead Sciences | FY | 2023 | $6.45 | $6.80 | $6.73 | $26.30B | $26.70B | $26.66B | Get Alert |
| 04/27/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.84 | $26.00B | $26.50B | $26.73B | Get Alert |
| 02/02/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.73 | $26.00B | $26.50B | $25.76B | Get Alert |
| 10/27/2022 | GILD | Gilead Sciences | FY | 2022 | $6.95 | $7.15 | $6.54 | $25.90B | $26.20B | $25.25B | Get Alert |
| 08/02/2022 | GILD | Gilead Sciences | FY | 2022 | $6.35 | $6.75 | $6.57 | $24.50B | $25.00B | $24.57B | Get Alert |
| 04/28/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.50 | $23.80B | $24.30B | $24.48B | Get Alert |
| 02/01/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.91 | $23.80B | $24.30B | $24.39B | Get Alert |
| 10/28/2021 | GILD | Gilead Sciences | FY | 2021 | $7.90 | $8.10 | $7.18 | $26.00B | $26.30B | $25.12B | Get Alert |
| 07/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.90 | $7.25 | $7.07 | $24.40B | $25.00B | $24.64B | Get Alert |
| 04/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $7.17 | $21.70B | $22.10B | $24.78B | Get Alert |
| 02/04/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $6.85 | $21.70B | $22.10B | $24.27B | Get Alert |
| 01/11/2021 | GILD | Gilead Sciences | FY | 2020 | $6.98 | $7.08 | $6.61 | $24.30B | $24.35B | $23.71B | Get Alert |
| 10/28/2020 | GILD | Gilead Sciences | FY | 2020 | $6.25 | $6.60 | $6.98 | $23.00B | $23.50B | $24.17B | Get Alert |
| 07/30/2020 | GILD | Gilead Sciences | FY | 2020 | $6.25 | $7.65 | $6.71 | $23.00B | $25.00B | $23.44B | Get Alert |
FAQ
What is the most recent guidance for Gilead Sciences (GILD)?
The most recent guidance for Gilead Sciences (GILD) was reported on February 11, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $7.70 to $8.10, compared to the estimated EPS of $7.60. Additionally, Gilead Sciences forecasted revenue between $28.20B and $28.60B for the quarter.
Browse guidance and forecast on all stocks.